taurine has been researched along with Alloxan Diabetes in 136 studies
Excerpt | Relevance | Reference |
---|---|---|
"The present study examined the protective effects of taurine on alloxan-induced diabetic cataracts and lens damage in male New Zealand White rabbits." | 7.78 | Protective effects of taurine against alloxan-induced diabetic cataracts and refraction changes in New Zealand White rabbits. ( Chen, YC; Chen, YY; Hsu, YW; Lin, SL; Tseng, JK; Yeh, SM, 2012) |
"Taurine (TAU) and compounds representing a TAU analog (hypotaurine = HYTAU) or homolog (aminomethanesulfonic acid = AMSA, homotaurine = HMTAU) were tested for their counteracting effects against alterations in erythrocyte (RBC) morphology, membrane fluidity and cytoskeletal spectrin distribution due to diabetes, alcoholism and diabetes-alcoholism in male Goto-Kakizaki rats (made diabetic with a high fat diet and alcoholic upon feeding on a flavored alcohol solution) and Wistar-Kyoto rats (serving as controls)." | 7.75 | The effects of taurine, hypotaurine, and taurine homologs on erythrocyte morphology, membrane fluidity and cytoskeletal spectrin alterations due to diabetes, alcoholism and diabetes-alcoholism in the rat. ( Gossai, D; Lau-Cam, CA, 2009) |
"The purpose of this study was to investigate whether taurine ameliorate the diabetic retinopathy, and to further explore the underlying mechanisms." | 7.74 | Dietary taurine supplementation ameliorates diabetic retinopathy via anti-excitotoxicity of glutamate in streptozotocin-induced Sprague-Dawley rats. ( Chen, F; Chen, K; Mi, M; Tang, Y; Wang, J; Wei, N; Xu, H; Xu, Z; Yu, X; Zeng, K; Zhang, Q; Zhu, J, 2008) |
"The intervening effect of taurine on STZ-induced diabetic cataract is dose-dependent." | 7.72 | [Study on the intervening mechanism of taurine on streptozotocin-induced diabetic cataracts]. ( Chen, CZ; Dong, B; Luo, GA; Shi, YY; Song, XD; Yan, LS; Zhang, W, 2003) |
"The effect of dietary taurine on hypercholesterolemia induced by a high-cholesterol diet in streptozotocin (STZ)-induced diabetic rats was investigated." | 7.70 | Improving effect of dietary taurine on marked hypercholesterolemia induced by a high-cholesterol diet in streptozotocin-induced diabetic rats. ( Mochizuki, H; Oda, H; Takido, J; Yokogoshi, H, 1999) |
"The protective effect of taurine in model in vitro diabetic cataract and the mechanism of this effect were investigated in isolated rat lenses." | 7.70 | Modelling cortical cataractogenesis 22: is in vitro reduction of damage in model diabetic rat cataract by taurine due to its antioxidant activity? ( Bhardwaj, R; Caulfeild, J; Kilic, F; Trevithick, JR, 1999) |
"The effects of taurine on insulin sensitivity were examined in a model rat of insulin resistance and type 2 diabetes-the Otsuka Long-Evans Tokushima Fatty (OLETF) rat." | 7.70 | Taurine improves insulin sensitivity in the Otsuka Long-Evans Tokushima Fatty rat, a model of spontaneous type 2 diabetes. ( Harada, N; Minami, A; Nakaya, Y; Niwa, Y; Ohnaka, M; Sakamoto, S, 2000) |
"Dietary taurine supplementation ameliorates MDA levels, GSSG/GSH, and NAD+/NADH and fails to prevent the osmotically mediated depletion of GSH and taurine and the decrease in glucose utilization and ATP levels in diabetic precataractous lens." | 7.70 | Effect of dietary taurine supplementation on GSH and NAD(P)-redox status, lipid peroxidation, and energy metabolism in diabetic precataractous lens. ( Obrosova, IG; Stevens, MJ, 1999) |
"Taurine was orally administered to rats in control+taurine and STZ + taurine groups daily for 8 weeks." | 5.39 | Taurine attenuates oxidative stress and alleviates cardiac failure in type I diabetic rats. ( Li, W; Lu, XH; Wang, GG; Xu, L; Zhao, X, 2013) |
"Taurine has also been shown to reduce lenticular oxidative stress." | 5.39 | Effects of magnesium taurate on the onset and progression of galactose-induced experimental cataract: in vivo and in vitro evaluation. ( Abdul Rahman, TH; Agarwal, P; Agarwal, R; Ahmad Fisol, NF; Awaludin, NA; Bakar, NS; Iezhitsa, I; Mohamed Ahmed Salama, MS; Mohd Ismail, N; Ozerov, A; Spasov, A, 2013) |
"Neither streptozotocin diabetes nor taurine in the diet appeared to affect the weight of the lenses." | 5.30 | Modelling cortical cataractogenesis 21: in diabetic rat lenses taurine supplementation partially reduces damage resulting from osmotic compensation leading to osmolyte loss and antioxidant depletion. ( Dzialoszynski, T; Linklater, HA; Mitton, KP; Sanford, SE; Starkey, K; Trevithick, JR, 1999) |
" The attenuated vasodilation in both cholesterol-fed and streptozotocin-induced diabetic mice was normalized by the chronic administration of taurine." | 5.29 | Restoration of endothelium-dependent relaxation in both hypercholesterolemia and diabetes by chronic taurine. ( Kamata, K; Kasuya, Y; Kojima, S; Sugiura, M, 1996) |
" Induction of diabetes by alloxan (ALX) (at a dose of 120mg/kg body weight, i." | 3.79 | Taurine ameliorate alloxan induced oxidative stress and intrinsic apoptotic pathway in the hepatic tissue of diabetic rats. ( Das, J; Rashid, K; Sil, PC, 2013) |
"The present study examined the protective effects of taurine on alloxan-induced diabetic cataracts and lens damage in male New Zealand White rabbits." | 3.78 | Protective effects of taurine against alloxan-induced diabetic cataracts and refraction changes in New Zealand White rabbits. ( Chen, YC; Chen, YY; Hsu, YW; Lin, SL; Tseng, JK; Yeh, SM, 2012) |
"Taurine (TAU) and compounds representing a TAU analog (hypotaurine = HYTAU) or homolog (aminomethanesulfonic acid = AMSA, homotaurine = HMTAU) were tested for their counteracting effects against alterations in erythrocyte (RBC) morphology, membrane fluidity and cytoskeletal spectrin distribution due to diabetes, alcoholism and diabetes-alcoholism in male Goto-Kakizaki rats (made diabetic with a high fat diet and alcoholic upon feeding on a flavored alcohol solution) and Wistar-Kyoto rats (serving as controls)." | 3.75 | The effects of taurine, hypotaurine, and taurine homologs on erythrocyte morphology, membrane fluidity and cytoskeletal spectrin alterations due to diabetes, alcoholism and diabetes-alcoholism in the rat. ( Gossai, D; Lau-Cam, CA, 2009) |
"The purpose of this study was to investigate whether taurine ameliorate the diabetic retinopathy, and to further explore the underlying mechanisms." | 3.74 | Dietary taurine supplementation ameliorates diabetic retinopathy via anti-excitotoxicity of glutamate in streptozotocin-induced Sprague-Dawley rats. ( Chen, F; Chen, K; Mi, M; Tang, Y; Wang, J; Wei, N; Xu, H; Xu, Z; Yu, X; Zeng, K; Zhang, Q; Zhu, J, 2008) |
"Peripheral hyperglycemia was associated with significant increases in brain sorbitol (7." | 3.74 | Hyperglycemia not hypoglycemia alters neuronal dendrites and impairs spatial memory. ( Chong, L; Diamond, DM; Hanna, S; Malone, JI; Mervis, RF; Park, CR; Saporta, S, 2008) |
"The intervening effect of taurine on STZ-induced diabetic cataract is dose-dependent." | 3.72 | [Study on the intervening mechanism of taurine on streptozotocin-induced diabetic cataracts]. ( Chen, CZ; Dong, B; Luo, GA; Shi, YY; Song, XD; Yan, LS; Zhang, W, 2003) |
"The effect of dietary taurine on hypercholesterolemia induced by a high-cholesterol diet in streptozotocin (STZ)-induced diabetic rats was investigated." | 3.70 | Improving effect of dietary taurine on marked hypercholesterolemia induced by a high-cholesterol diet in streptozotocin-induced diabetic rats. ( Mochizuki, H; Oda, H; Takido, J; Yokogoshi, H, 1999) |
"The effects of taurine on insulin sensitivity were examined in a model rat of insulin resistance and type 2 diabetes-the Otsuka Long-Evans Tokushima Fatty (OLETF) rat." | 3.70 | Taurine improves insulin sensitivity in the Otsuka Long-Evans Tokushima Fatty rat, a model of spontaneous type 2 diabetes. ( Harada, N; Minami, A; Nakaya, Y; Niwa, Y; Ohnaka, M; Sakamoto, S, 2000) |
"The protective effect of taurine in model in vitro diabetic cataract and the mechanism of this effect were investigated in isolated rat lenses." | 3.70 | Modelling cortical cataractogenesis 22: is in vitro reduction of damage in model diabetic rat cataract by taurine due to its antioxidant activity? ( Bhardwaj, R; Caulfeild, J; Kilic, F; Trevithick, JR, 1999) |
"Dietary taurine supplementation ameliorates MDA levels, GSSG/GSH, and NAD+/NADH and fails to prevent the osmotically mediated depletion of GSH and taurine and the decrease in glucose utilization and ATP levels in diabetic precataractous lens." | 3.70 | Effect of dietary taurine supplementation on GSH and NAD(P)-redox status, lipid peroxidation, and energy metabolism in diabetic precataractous lens. ( Obrosova, IG; Stevens, MJ, 1999) |
"It has been suggested that sugar cataracts associated with diabetes mellitus result from the accumulation of excess sorbitol within lens fibrils." | 3.68 | Nonosmotic diabetic cataracts. ( Cook, WR; Lowitt, S; Malone, JI, 1990) |
"Taurine in diabetes has an age old story; taurine is involved in the development and protection of insulin apparatus." | 2.44 | Taurine-diabetes interaction: from involvement to protection. ( Gupta, RC; Kim, SJ; Lee, HW, 2007) |
"Taurine is known to inhibit the phosphorylation of PDH in vitro, and in taurine-depleted rats PDH phosphorylation is known to increase." | 2.41 | The role of taurine in the pathogenesis of the cardiomyopathy of insulin-dependent diabetes mellitus. ( Lombardini, JB; Militante, JD; Schaffer, SW, 2000) |
"Taurine is a semi-essential amino acid in mammals and has been shown to be a potent endogenous antioxidant." | 1.72 | Taurine Ameliorates Apoptosis via AKT Pathway in the Kidney of Diabetic Rats. ( Li, S; Piao, F; Wang, D; Zhang, C; Zhang, M, 2022) |
"Taurine could inhibit hippocampus neuron apoptosis via NGF-Akt/Bad pathway." | 1.56 | Taurine inhibits neuron apoptosis in hippocampus of diabetic rats and high glucose exposed HT-22 cells via the NGF-Akt/Bad pathway. ( Che, X; Chen, X; Li, K; Li, Q; Li, S; Li, Y; Liu, X; Liu, Y; Luo, M; Ma, J; Piao, F; Shi, X; Wu, P; Zhang, C; Zhang, M, 2020) |
"Taurine has been found to ameliorate the diabetic neuropathy and control apoptosis in various tissues." | 1.51 | Protective Effect of Taurine on Apoptosis of Spinal Cord Cells in Diabetic Neuropathy Rats. ( Li, K; Piao, F; Shahbaz, M; Shi, X; Suleman, R; Taj, A; Wu, P; Zhang, M, 2019) |
"Type 1 diabetes mellitus was induced in male rats by using streptozotocin." | 1.43 | Taurine Supplementation Improves Erectile Function in Rats with Streptozotocin-induced Type 1 Diabetes via Amelioration of Penile Fibrosis and Endothelial Dysfunction. ( Li, M; Liu, J; Rao, K; Ruan, Y; Wang, S; Wang, T; Yang, J; Yang, W; Ye, Z, 2016) |
"Taurine was administered orally for 12 weeks (1% w/v in drinking water) from the day on which STZ was injected." | 1.40 | Chronic treatment with taurine ameliorates diabetes-induced dysfunction of nitric oxide-mediated neurogenic and endothelium-dependent corpus cavernosum relaxation in rats. ( Bayram, Z; Celik-Ozenci, C; Dalaklioglu, S; Kuscu, N; Nacitarhan, C; Ozdem, SS, 2014) |
" Diabetes-induced cardiac dysfunction and increases in plasma triglycerides can be prevented, but not reversed, by dietary cysteine alone or in combination with taurine." | 1.39 | Cardioprotective effects of cysteine alone or in combination with taurine in diabetes. ( Aroutiounova, N; Dhalla, NS; Rodriguez-Leyva, D; Tappia, PS; Xu, YJ, 2013) |
"Taurine was orally administered to rats in control+taurine and STZ + taurine groups daily for 8 weeks." | 1.39 | Taurine attenuates oxidative stress and alleviates cardiac failure in type I diabetic rats. ( Li, W; Lu, XH; Wang, GG; Xu, L; Zhao, X, 2013) |
"Taurine has also been shown to reduce lenticular oxidative stress." | 1.39 | Effects of magnesium taurate on the onset and progression of galactose-induced experimental cataract: in vivo and in vitro evaluation. ( Abdul Rahman, TH; Agarwal, P; Agarwal, R; Ahmad Fisol, NF; Awaludin, NA; Bakar, NS; Iezhitsa, I; Mohamed Ahmed Salama, MS; Mohd Ismail, N; Ozerov, A; Spasov, A, 2013) |
"Edaravone or taurine treatment prevented significantly the decreased body, testicular, and epididymal weight induced by diabetes." | 1.38 | Antioxidant treatment with edaravone or taurine ameliorates diabetes-induced testicular dysfunction in the rat. ( Dimitriadis, F; Koukos, S; Saito, M; Satoh, K; Shimizu, S; Sofikitis, N; Takenaka, A; Tsounapi, P, 2012) |
"Diabetes during pregnancy affects >5% of all pregnancies, causing reproductive abnormalities that enhance spontaneous abortion - congenital anomalies, morbidity and mortality of both mother and fetus/newborn." | 1.38 | Taurine attenuates maternal and embryonic oxidative stress in a streptozotocin-diabetic rat model. ( Shivananjappa, MM, 2012) |
"Taurine was administered orally for 3 weeks (1% w/v in drinking water) either from the day on which alloxan was injected or after the onset of diabetes." | 1.38 | Taurine ameliorates alloxan-induced diabetic renal injury, oxidative stress-related signaling pathways and apoptosis in rats. ( Das, J; Sil, PC, 2012) |
"Taurine treatment could, however, result to a decrease in the elevated blood glucose and proinflammatory cytokine levels, diabetes-evoked oxidative stress, lipid profiles and NFκB translocation." | 1.38 | Taurine exerts hypoglycemic effect in alloxan-induced diabetic rats, improves insulin-mediated glucose transport signaling pathway in heart and ameliorates cardiac oxidative stress and apoptosis. ( Das, J; Sil, PC; Vasan, V, 2012) |
"Taurine was effective more than melatonin in reducing CYP2E1 activity and expression; therefore antioxidants might prove beneficial in type 1 diabetes associated with manifestations of liver injury." | 1.37 | Taurine is more effective than melatonin on cytochrome P450 2E1 and some oxidative stress markers in streptozotocin-induced diabetic rats. ( El-Batch, M; Hassan, AM; Mahmoud, HA, 2011) |
"Taurine could enhance the ability of oxidation resistance, improve blood rheology property in diabetic rats, at the same time it could be beneficial to prevent and cure the development of diabetic blood vessel complication." | 1.36 | [Effects of taurine on hemorheology of rats with type 2 diabetes]. ( Dong, SY; Kong, XY; Men, XL; Zhang, FF; Zhang, YM; Zhao, LJ, 2010) |
"Taurine was administered to type diabetic rats induced by high fat high sugar diet combined with STZ injection." | 1.36 | Preventive effect of taurine on experimental type II diabetic nephropathy. ( Hu, J; Lin, S; Liu, M; Luan, X; Lv, Q; Wu, G; Yang, J; Zhao, H, 2010) |
" Hence, dosing will play a critical role in clinical studies assessing the merits of NIC and TAU as diabetes-preventing agents." | 1.36 | Comparative study of the binding characteristics to and inhibitory potencies towards PARP and in vivo antidiabetogenic potencies of taurine, 3-aminobenzamide and nicotinamide. ( Lau-Cam, CA; Pandya, KG; Patel, MR, 2010) |
"The etiology of painful diabetic neuropathy is poorly understood, but may result from neuronal hyperexcitability secondary to alterations of Ca2+ signaling in sensory neurons." | 1.33 | Taurine replacement attenuates hyperalgesia and abnormal calcium signaling in sensory neurons of STZ-D rats. ( Abatan, O; Larkin, D; Li, F; Obrosova, IG; Stevens, MJ; Stuenkel, EL; Tian, D, 2005) |
"Taurine was administered to diabetic rats from 2 days to 4 weeks after streptozotocin injection." | 1.33 | Reactive oxygen species mediate high glucose-induced plasminogen activator inhibitor-1 up-regulation in mesangial cells and in diabetic kidney. ( Ha, H; Jiang, Z; Kwon, MK; Lee, EA; Lee, HB; Seo, JY; Yu, MR, 2005) |
"Glycine-treated diabetic rats showed an important diminution in the percentage of animals with opacity in lens and microaneurysms in the eyes." | 1.33 | Oral glycine administration attenuates diabetic complications in streptozotocin-induced diabetic rats. ( Alvarado-Vásquez, N; Carvajal-Sandoval, G; Cerón, E; Guevara, J; Lascurain, R; Montaño, LF; Tapia, A; Vanda, B; Zenteno, E, 2006) |
"Oxerutin treatment and the combined NAC plus taurine treatment resulted in reduced accumulation of collagen-linked fluorescence in skin in comparison with untreated diabetic rats." | 1.32 | Comparative trial of N-acetyl-cysteine, taurine, and oxerutin on skin and kidney damage in long-term experimental diabetes. ( Cosso, L; Cottalasso, D; Maineri, EP; Marinari, UM; Menini, S; Odetti, P; Patriarca, S; Pesce, C; Pronzato, MA; Traverso, N; Valentini, S, 2003) |
"Flurbiprofen treatment of ND rats replicated many of the biochemical and physiological abnormalities of EDN, i." | 1.31 | Dissection of metabolic, vascular, and nerve conduction interrelationships in experimental diabetic neuropathy by cyclooxygenase inhibition and acetyl-L-carnitine administration. ( Greene, DA; Larkin, D; Li, F; Marinescu, V; Pop-Busui, R; Stevens, MJ; Sullivan, K; Van Huysen, C, 2002) |
"Taurine was given in drinking water at the level of 5% (w/v) for seven days." | 1.30 | Effect of taurine supplementation on the lipid peroxide formation and the activities of glutathione-related enzymes in the liver and islet of type I and II diabetic model mice. ( Kim, H; Lim, E; Park, S, 1998) |
" Chronic administration of melatonin (n = 6) and taurine (n = 6) prevented increases in glomerular TGF-beta1 and fibronectin mRNAs and proteinuria without having effect on blood glucose." | 1.30 | Melatonin and taurine reduce early glomerulopathy in diabetic rats. ( Ha, H; Kim, KH; Yu, MR, 1999) |
"Neither streptozotocin diabetes nor taurine in the diet appeared to affect the weight of the lenses." | 1.30 | Modelling cortical cataractogenesis 21: in diabetic rat lenses taurine supplementation partially reduces damage resulting from osmotic compensation leading to osmolyte loss and antioxidant depletion. ( Dzialoszynski, T; Linklater, HA; Mitton, KP; Sanford, SE; Starkey, K; Trevithick, JR, 1999) |
"Taurine was without significant effect on the time course of the Ca2+ transient decay in control cells, however, in diabetic cells it significantly accelerated the rate of decay." | 1.30 | Acute effects of taurine on intracellular calcium in normal and diabetic cardiac myocytes. ( Holloway, C; Kotsanas, G; Wendt, I, 1999) |
"Normal rats, those with streptozocin diabetes, puromycin aminonucleoside nephropathy, bilateral ureteral ligation, and 5/6 nephrectomy were studied." | 1.29 | Immunohistochemical localization of taurine in rat renal tissue: studies in experimental disease states. ( Lu, P; Sturman, JA; Trachtman, H, 1993) |
" The attenuated vasodilation in both cholesterol-fed and streptozotocin-induced diabetic mice was normalized by the chronic administration of taurine." | 1.29 | Restoration of endothelium-dependent relaxation in both hypercholesterolemia and diabetes by chronic taurine. ( Kamata, K; Kasuya, Y; Kojima, S; Sugiura, M, 1996) |
"Taurine is a cerebral osmolyte whose intracellular content changes in parallel with plasma osmolality." | 1.28 | Cerebral taurine transport is increased during streptozocin-induced diabetes in rats. ( Futterweit, S; Sturman, JA; Trachtman, H, 1992) |
" Taurine administration at relatively low dosage ameliorated only kidney taurine concentration." | 1.28 | Supplemental taurine in diabetic rats: effects on plasma glucose and triglycerides. ( Goodman, HO; Shihabi, ZK, 1990) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (2.21) | 18.7374 |
1990's | 23 (16.91) | 18.2507 |
2000's | 48 (35.29) | 29.6817 |
2010's | 51 (37.50) | 24.3611 |
2020's | 11 (8.09) | 2.80 |
Authors | Studies |
---|---|
Li, S | 5 |
Wang, D | 1 |
Zhang, M | 7 |
Zhang, C | 5 |
Piao, F | 8 |
Gao, B | 1 |
Yuan, X | 1 |
Sun, X | 1 |
Zhang, Q | 4 |
Clark, GJ | 2 |
Pandya, K | 2 |
Lau-Cam, CA | 12 |
Zhou, Z | 1 |
Zhang, X | 2 |
Xu, L | 2 |
Lu, H | 1 |
Chen, Y | 1 |
Wu, C | 1 |
Hu, P | 1 |
Ural, C | 1 |
Celik, A | 1 |
Ozbal, S | 1 |
Guneli, E | 1 |
Arslan, S | 1 |
Ergur, BU | 1 |
Cavdar, C | 1 |
Akdoğan, G | 1 |
Cavdar, Z | 1 |
Li, K | 5 |
Shi, X | 6 |
Luo, M | 3 |
Wu, P | 5 |
Li, Q | 4 |
Wang, Y | 6 |
Patel, SN | 3 |
Suleman, R | 3 |
Nisar, A | 1 |
Shahbaz, M | 1 |
Taj, A | 1 |
Qiu, Z | 1 |
Aadil, RM | 1 |
Tian, J | 1 |
Dang, H | 1 |
O'Laco, KA | 1 |
Song, M | 1 |
Tiu, BC | 1 |
Gilles, S | 1 |
Zakarian, C | 1 |
Kaufman, DL | 1 |
Zhang, R | 1 |
Wang, X | 2 |
Gao, Q | 1 |
Jiang, H | 1 |
Zhang, S | 1 |
Lu, M | 1 |
Liu, F | 1 |
Xue, X | 1 |
Ma, J | 1 |
Li, Y | 2 |
Liu, Y | 1 |
Liu, X | 2 |
Chen, X | 2 |
Che, X | 1 |
Luo, Y | 1 |
Tian, Y | 1 |
Zhao, C | 1 |
Sedaghat, M | 1 |
Choobineh, S | 1 |
Ravasi, AA | 1 |
Lan, Q | 1 |
Ullah, H | 1 |
Hanafy, MM | 1 |
Lindeque, JZ | 1 |
El-Maraghy, SA | 1 |
Abdel-Hamid, AZ | 1 |
Shahin, NN | 1 |
Caletti, G | 4 |
Herrmann, AP | 1 |
Pulcinelli, RR | 2 |
Steffens, L | 1 |
Morás, AM | 1 |
Vianna, P | 1 |
Chies, JAB | 1 |
Moura, DJ | 1 |
Barros, HMT | 2 |
Gomez, R | 4 |
Wei, M | 1 |
Shao, Y | 1 |
Liu, QR | 1 |
Wu, QZ | 1 |
Zhong, MW | 1 |
Liu, SZ | 1 |
Zhang, GY | 1 |
Hu, SY | 1 |
Arbo, BD | 1 |
Hoefel, AL | 1 |
Schneider, R | 1 |
Hansen, AW | 1 |
Freese, L | 1 |
Bandiera, S | 1 |
Kucharski, LC | 1 |
Ghosh, S | 1 |
Chowdhury, S | 1 |
Das, AK | 1 |
Sil, PC | 5 |
Agarwal, R | 1 |
Iezhitsa, I | 1 |
Awaludin, NA | 1 |
Ahmad Fisol, NF | 1 |
Bakar, NS | 1 |
Agarwal, P | 1 |
Abdul Rahman, TH | 1 |
Spasov, A | 1 |
Ozerov, A | 1 |
Mohamed Ahmed Salama, MS | 1 |
Mohd Ismail, N | 1 |
Manna, P | 1 |
Das, J | 4 |
Wang, GG | 1 |
Li, W | 1 |
Lu, XH | 1 |
Zhao, X | 1 |
Dalaklioglu, S | 1 |
Kuscu, N | 1 |
Celik-Ozenci, C | 1 |
Bayram, Z | 1 |
Nacitarhan, C | 1 |
Ozdem, SS | 2 |
Agca, CA | 1 |
Tuzcu, M | 1 |
Hayirli, A | 1 |
Sahin, K | 1 |
Bessho, M | 1 |
Murase-Mishiba, Y | 1 |
Imagawa, A | 1 |
Terasaki, J | 1 |
Hanafusa, T | 1 |
Almeida, FB | 1 |
Agnes, G | 1 |
Nin, MS | 1 |
Barros, HM | 2 |
Han, X | 1 |
Ito, T | 2 |
Azuma, J | 2 |
Schaffer, SW | 5 |
Chesney, RW | 1 |
Pandya, KG | 4 |
Budhram, R | 3 |
Parikh, M | 1 |
Parikh, MC | 1 |
Shen, Y | 1 |
Zhang, H | 1 |
Huang, M | 1 |
Gao, L | 1 |
Lei, H | 1 |
Ruan, Y | 2 |
Li, M | 2 |
Wang, T | 2 |
Yang, J | 3 |
Rao, K | 2 |
Wang, S | 2 |
Yang, W | 2 |
Liu, J | 2 |
Ye, Z | 2 |
Abd El-Twab, SM | 1 |
Mohamed, HM | 1 |
Mahmoud, AM | 1 |
Li, J | 1 |
Qin, F | 1 |
Yuan, J | 1 |
Tsounapi, P | 3 |
Honda, M | 1 |
Dimitriadis, F | 3 |
Shimizu, S | 3 |
Shiomi, T | 1 |
Hikita, K | 1 |
Saito, M | 3 |
Tomita, S | 1 |
Sofikitis, N | 2 |
Takenaka, A | 2 |
Zeng, K | 3 |
Xu, H | 3 |
Mi, M | 3 |
Zhang, Y | 2 |
Chen, K | 3 |
Chen, F | 2 |
Zhu, J | 3 |
Yu, X | 3 |
Wang, L | 1 |
Zhang, L | 1 |
Yu, Y | 1 |
Niu, N | 3 |
Wang, LJ | 2 |
Yu, YH | 2 |
Zhang, LG | 1 |
Guo, LM | 2 |
Winiarska, K | 1 |
Szymanski, K | 1 |
Gorniak, P | 1 |
Dudziak, M | 1 |
Bryla, J | 1 |
Malone, JI | 2 |
Hanna, S | 1 |
Saporta, S | 1 |
Mervis, RF | 1 |
Park, CR | 1 |
Chong, L | 1 |
Diamond, DM | 1 |
Gavrovskaya, LK | 1 |
Ryzhova, OV | 1 |
Safonova, AF | 1 |
Matveev, AK | 1 |
Sapronov, NS | 1 |
Gossai, D | 2 |
Jensen-Waern, M | 1 |
Andersson, M | 1 |
Kruse, R | 1 |
Nilsson, B | 1 |
Larsson, R | 1 |
Korsgren, O | 1 |
Essén-Gustavsson, B | 1 |
Yao, HT | 1 |
Lin, P | 1 |
Chang, YW | 1 |
Chen, CT | 1 |
Chiang, MT | 1 |
Chang, L | 1 |
Kuo, YC | 1 |
Tsai, HT | 1 |
Yeh, TK | 1 |
Duarte, JM | 1 |
Carvalho, RA | 1 |
Cunha, RA | 1 |
Gruetter, R | 1 |
Gaamoussi, F | 1 |
Israili, ZH | 1 |
Lyoussi, B | 1 |
Yi, L | 1 |
Zhang, T | 1 |
Patel, MR | 1 |
Lin, S | 1 |
Wu, G | 1 |
Liu, M | 1 |
Luan, X | 1 |
Lv, Q | 1 |
Zhao, H | 1 |
Hu, J | 1 |
Zhang, FF | 1 |
Zhang, YM | 1 |
Men, XL | 1 |
Zhao, LJ | 1 |
Kong, XY | 1 |
Dong, SY | 1 |
El-Batch, M | 1 |
Hassan, AM | 1 |
Mahmoud, HA | 1 |
Ikubo, N | 1 |
Ohmasa, F | 1 |
Inoue, S | 1 |
Kinoshita, Y | 1 |
Satoh, K | 2 |
Lee, E | 1 |
Ryu, GR | 1 |
Ko, SH | 1 |
Ahn, YB | 1 |
Yoon, KH | 1 |
Ha, H | 3 |
Song, KH | 1 |
Vasan, V | 1 |
El Zahraa Z El Ashry, F | 1 |
Mahmoud, MF | 1 |
El Maraghy, NN | 1 |
Ahmed, AF | 1 |
Olguins, DB | 1 |
Pedrollo, EF | 1 |
Furfaro, AL | 3 |
Nitti, M | 1 |
Marengo, B | 1 |
Domenicotti, C | 2 |
Cottalasso, D | 4 |
Marinari, UM | 4 |
Pronzato, MA | 4 |
Traverso, N | 4 |
Shivananjappa, MM | 1 |
Koukos, S | 1 |
Hsu, YW | 1 |
Yeh, SM | 1 |
Chen, YY | 1 |
Chen, YC | 1 |
Lin, SL | 1 |
Tseng, JK | 1 |
Rashid, K | 1 |
Yun, KU | 1 |
Ryu, CS | 1 |
Lee, JY | 1 |
Noh, JR | 1 |
Lee, CH | 1 |
Lee, HS | 1 |
Kang, JS | 1 |
Park, SK | 1 |
Kim, BH | 1 |
Kim, SK | 1 |
Tappia, PS | 1 |
Xu, YJ | 1 |
Rodriguez-Leyva, D | 1 |
Aroutiounova, N | 1 |
Dhalla, NS | 1 |
Mathew, E | 1 |
Barletta, MA | 1 |
Pop-Busui, R | 2 |
Marinescu, V | 2 |
Van Huysen, C | 4 |
Li, F | 2 |
Sullivan, K | 1 |
Greene, DA | 3 |
Larkin, D | 2 |
Stevens, MJ | 8 |
Di Leo, MA | 4 |
Santini, SA | 4 |
Cercone, S | 1 |
Lepore, D | 2 |
Gentiloni Silveri, N | 3 |
Caputo, S | 3 |
Greco, AV | 1 |
Giardina, B | 4 |
Franconi, F | 5 |
Ghirlanda, G | 5 |
Odetti, P | 3 |
Pesce, C | 2 |
Menini, S | 2 |
Maineri, EP | 1 |
Cosso, L | 1 |
Valentini, S | 1 |
Patriarca, S | 3 |
Mozaffari, MS | 2 |
Miyata, N | 1 |
Lee, YM | 1 |
Choi, MJ | 1 |
Chang, KJ | 4 |
Tenner, TE | 1 |
Zhang, XJ | 1 |
Lombardini, JB | 2 |
Song, XD | 1 |
Chen, CZ | 1 |
Dong, B | 1 |
Shi, YY | 1 |
Zhang, W | 1 |
Yan, LS | 1 |
Luo, GA | 1 |
Colivicchi, MA | 1 |
Raimondi, L | 1 |
Bianchi, L | 1 |
Tipton, KF | 1 |
Pirisino, R | 1 |
Della Corte, L | 1 |
Han, J | 1 |
Bae, JH | 1 |
Kim, SY | 1 |
Lee, HY | 1 |
Jang, BC | 1 |
Lee, IK | 1 |
Cho, CH | 1 |
Lim, JG | 1 |
Suh, SI | 1 |
Kwon, TK | 1 |
Park, JW | 1 |
Ryu, SY | 1 |
Ho, WK | 1 |
Earm, YE | 1 |
Song, DK | 1 |
Silveri, NG | 1 |
Obrosova, IG | 5 |
Abatan, O | 1 |
Tian, D | 1 |
Stuenkel, EL | 1 |
Lee, EA | 1 |
Seo, JY | 1 |
Jiang, Z | 1 |
Yu, MR | 2 |
Kwon, MK | 1 |
Lee, HB | 1 |
Li, C | 1 |
Cao, L | 1 |
Zeng, Q | 1 |
Dai, T | 1 |
Hu, D | 1 |
Huang, K | 1 |
Li, D | 1 |
Chen, Z | 1 |
Zhang, J | 1 |
Sharma, R | 1 |
Alvarado-Vásquez, N | 1 |
Lascurain, R | 1 |
Cerón, E | 1 |
Vanda, B | 1 |
Carvajal-Sandoval, G | 1 |
Tapia, A | 1 |
Guevara, J | 1 |
Montaño, LF | 1 |
Zenteno, E | 1 |
Abdelsayed, R | 1 |
Patel, C | 1 |
Tas, S | 1 |
Sarandol, E | 1 |
Ayvalik, SZ | 1 |
Serdar, Z | 1 |
Dirican, M | 1 |
Shrilatha, B | 1 |
Xu, Z | 1 |
Wei, N | 1 |
Wang, J | 1 |
Tang, Y | 1 |
Abebe, W | 1 |
Kim, SJ | 1 |
Gupta, RC | 1 |
Lee, HW | 1 |
Atlas, M | 1 |
Bahl, JJ | 1 |
Roeske, W | 1 |
Bressler, R | 1 |
Trachtman, H | 4 |
Futterweit, S | 2 |
Maesaka, J | 1 |
Ma, C | 1 |
Valderrama, E | 1 |
Fuchs, A | 1 |
Tarectecan, AA | 1 |
Rao, PS | 1 |
Sturman, JA | 3 |
Boles, TH | 1 |
Medow, MS | 1 |
Kletter, LB | 1 |
Lu, P | 1 |
Lattimer, SA | 1 |
Kamijo, M | 1 |
Sima, AA | 1 |
Kamata, K | 1 |
Sugiura, M | 1 |
Kojima, S | 1 |
Kasuya, Y | 1 |
Dawson, R | 1 |
Eppler, B | 1 |
Patterson, TA | 1 |
Shih, D | 1 |
Liu, S | 1 |
Shibata, Y | 1 |
Ohta, T | 1 |
Nakatsuka, M | 1 |
Ishizu, H | 1 |
Matsuda, Y | 1 |
Shindo, T | 1 |
Takeuchi, F | 1 |
Yoshino, M | 1 |
Hirano, S | 1 |
Noguchi, T | 1 |
Tatsumi, T | 1 |
Matoba, S | 1 |
Kawahara, A | 1 |
Kobara, M | 1 |
Tsuruyama, K | 1 |
Tanaka, T | 1 |
Nakagawa, C | 1 |
Ohta, B | 1 |
Asayama, J | 1 |
Nakagawa, M | 1 |
Nanami, K | 1 |
Oda, H | 2 |
Yokogoshi, H | 2 |
Miceli, M | 1 |
Fazzini, A | 1 |
Seghieri, G | 1 |
DiLeo, MA | 1 |
Vilchis, C | 1 |
Salceda, R | 1 |
Lim, E | 1 |
Park, S | 1 |
Kim, H | 1 |
You, JS | 1 |
Kim, KH | 1 |
Holloway, C | 1 |
Kotsanas, G | 1 |
Wendt, I | 1 |
Mitton, KP | 1 |
Linklater, HA | 1 |
Dzialoszynski, T | 1 |
Sanford, SE | 1 |
Starkey, K | 1 |
Trevithick, JR | 2 |
Kilic, F | 1 |
Bhardwaj, R | 1 |
Caulfeild, J | 1 |
Nakaya, Y | 1 |
Minami, A | 1 |
Harada, N | 1 |
Sakamoto, S | 1 |
Niwa, Y | 1 |
Ohnaka, M | 1 |
Mochizuki, H | 1 |
Takido, J | 1 |
Sadan, G | 1 |
Usta, C | 1 |
Taşatargil, A | 1 |
Militante, JD | 1 |
Guyot, LL | 1 |
Diaz, FG | 1 |
O'Regan, MH | 1 |
Song, D | 1 |
Phillis, JW | 1 |
Fathallah, L | 3 |
Cao, X | 2 |
Aerts, L | 1 |
Van Assche, FA | 1 |
Sullivan, KA | 1 |
Bayer, L | 1 |
Towns, R | 1 |
Minchenko, AG | 1 |
Kennedy, A | 1 |
Stockert, CM | 1 |
Frank, RN | 1 |
Rose, SJ | 1 |
Bushi, M | 1 |
Nagra, I | 1 |
Davies, WE | 1 |
Kwon, W | 1 |
Reibel, DK | 1 |
Shaffer, JE | 1 |
Kocsis, JJ | 1 |
Neely, JR | 1 |
Siow, Y | 1 |
Schurr, A | 1 |
Vitale, GC | 1 |
Lowitt, S | 1 |
Cook, WR | 1 |
Goodman, HO | 1 |
Shihabi, ZK | 1 |
Sadahiro, R | 1 |
Takeuchi, N | 1 |
Kumagai, A | 1 |
Yamamura, Y | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Effect of Taurine on Glycemic, Lipid and Inflammatory Profile in Individuals With Type 2 Diabetes: a Randomized Clinical Trial[NCT04874012] | Phase 2 | 94 participants (Anticipated) | Interventional | 2021-06-12 | Recruiting | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
5 reviews available for taurine and Alloxan Diabetes
Article | Year |
---|---|
Role of sulfur containing amino acids as an adjuvant therapy in the prevention of diabetes and its associated complications.
Topics: 3T3-L1 Cells; Amino Acids, Sulfur; Animals; Blood Glucose; Cells, Cultured; Cysteine; Diabetes Melli | 2013 |
Taurine ameliorates neuropathy via regulating NF-κB and Nrf2/HO-1 signaling cascades in diabetic rats.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Heme Oxygenase-1; NF-E2-Related Fac | 2014 |
The potential usefulness of taurine on diabetes mellitus and its complications.
Topics: Animals; Diabetes Complications; Diabetes Mellitus, Experimental; Disease Models, Animal; Glycation | 2012 |
Taurine-diabetes interaction: from involvement to protection.
Topics: Animals; Coronary Artery Disease; Diabetes Complications; Diabetes Mellitus, Experimental; Diabetes | 2007 |
The role of taurine in the pathogenesis of the cardiomyopathy of insulin-dependent diabetes mellitus.
Topics: Animals; Cardiomyopathies; Diabetes Mellitus, Experimental; Energy Metabolism; Feedback; Isoenzymes; | 2000 |
131 other studies available for taurine and Alloxan Diabetes
Article | Year |
---|---|
Taurine Ameliorates Apoptosis via AKT Pathway in the Kidney of Diabetic Rats.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Caspase 9; Diabetes Mellitus, Experimenta | 2022 |
Taurine Ameliorates Oxidative Stress in Spinal Cords of Diabetic Rats via Keap1-Nrf2 Signaling.
Topics: Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; GAP-43 Protein; Kelch-Like ECH | 2022 |
Assessment of In Vitro Tests as Predictors of the Antioxidant Effects of Insulin, Metformin, and Taurine in the Brain of Diabetic Rats.
Topics: Animals; Antioxidants; Blood Glucose; Brain; Diabetes Mellitus, Experimental; Glutathione; Hyperglyc | 2022 |
A self-healing hydrogel based on crosslinked hyaluronic acid and chitosan to facilitate diabetic wound healing.
Topics: Animals; Anti-Inflammatory Agents; Chitosan; Cytokines; Diabetes Mellitus, Experimental; Hyaluronic | 2022 |
The renoprotective effects of taurine against diabetic nephropathy via the p38 MAPK and TGF-β/Smad2/3 signaling pathways.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Extracellular Matrix Proteins; Kid | 2023 |
Taurine protects against myelin damage of sciatic nerve in diabetic peripheral neuropathy rats by controlling apoptosis of schwann cells via NGF/Akt/GSK3β pathway.
Topics: Animals; Apoptosis; Demyelinating Diseases; Diabetes Mellitus, Experimental; Diabetic Neuropathies; | 2019 |
Taurine Improves the Actions of Metformin and Lovastatin on Plasma Markers of Carbohydrate and Lipid Dysfunction of Diabetic Rats.
Topics: Animals; Blood Glucose; Carbohydrates; Diabetes Mellitus, Experimental; Hypoglycemic Agents; Hypolip | 2019 |
Modification by Ethanol and Taurine, Singly and in Combination, of Changes in Indices of Renal Dysfunction Caused by Diabetes in Rats.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Ethanol; Kidney Diseases; Male; Rats; Rats, | 2019 |
Anti-apoptotic Effect of Taurine on Schwann Cells Exposed to High Glucose In Vitro.
Topics: Animals; Apoptosis; Cells, Cultured; Diabetes Mellitus, Experimental; Glucose; Rats; Schwann Cells; | 2019 |
Protective Effect of Taurine on Apoptosis of Spinal Cord Cells in Diabetic Neuropathy Rats.
Topics: Animals; Apoptosis; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Male; Rats; Rats, Spragu | 2019 |
The microRNAs Expression Profile in Sciatic Nerves of Diabetic Neuropathy Rats After Taurine Treatment by Sequencing.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Neuropathies; MicroRNAs; Rats; Sciatic Nerve; Tau | 2019 |
Homotaurine Treatment Enhances CD4
Topics: Animals; Blood Glucose; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Diabetes Mellitus, E | 2019 |
Taurine Supplementation Reverses Diabetes-Induced Podocytes Injury via Modulation of the CSE/TRPC6 Axis and Improvement of Mitochondrial Function.
Topics: Animals; Apoptosis; Calcium; Cells, Cultured; Cystathionine gamma-Lyase; Diabetes Mellitus, Experime | 2020 |
Taurine inhibits neuron apoptosis in hippocampus of diabetic rats and high glucose exposed HT-22 cells via the NGF-Akt/Bad pathway.
Topics: Animals; Apoptosis; bcl-Associated Death Protein; Diabetes Mellitus, Experimental; Diabetes Mellitus | 2020 |
Taurine attenuates liver autophagy and injury of offspring in gestational diabetic mellitus rats.
Topics: Animals; Autophagy; Diabetes Mellitus, Experimental; Diabetes, Gestational; Diet, High-Fat; Dietary | 2020 |
Taurine with combined aerobic and resistance exercise training alleviates myocardium apoptosis in STZ-induced diabetes rats via Akt signaling pathway.
Topics: Animals; Apoptosis; Combined Modality Therapy; Diabetes Mellitus, Experimental; Male; Myocardium; Ph | 2020 |
Taurine ameliorates axonal damage in sciatic nerve of diabetic rats and high glucose exposed DRG neuron by PI3K/Akt/mTOR-dependent pathway.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Ganglia, Spinal; In | 2021 |
Time-based investigation of urinary metabolic markers for Type 2 diabetes: Metabolomics approach for diabetes management.
Topics: Animals; Biomarkers; Carnitine; Cluster Analysis; Deoxyglucose; Diabetes Mellitus, Experimental; Dis | 2021 |
Taurine counteracts the neurotoxic effects of streptozotocin-induced diabetes in rats.
Topics: Animals; Antioxidants; Brain; Cytokines; Diabetes Mellitus, Experimental; DNA Damage; Male; Oxidativ | 2018 |
Bile acid profiles within the enterohepatic circulation in a diabetic rat model after bariatric surgeries.
Topics: Animals; Bariatric Surgery; Bile Acids and Salts; Blood Glucose; Body Weight; Diabetes Mellitus, Exp | 2018 |
Acute intraperitoneal administration of taurine decreases the glycemia and reduces food intake in type 1 diabetic rats.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Eating; Hypoglyc | 2018 |
Taurine ameliorates oxidative stress induced inflammation and ER stress mediated testicular damage in STZ-induced diabetic Wistar rats.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Apoptosis; Biomarkers; Catalase; Chemokines; Diabet | 2019 |
Effects of magnesium taurate on the onset and progression of galactose-induced experimental cataract: in vivo and in vitro evaluation.
Topics: Administration, Oral; Administration, Topical; Animals; Calcium; Catalase; Cataract; Diabetes Mellit | 2013 |
Taurine attenuates oxidative stress and alleviates cardiac failure in type I diabetic rats.
Topics: Animals; Blood Glucose; Blotting, Western; Body Weight; Diabetes Mellitus, Experimental; Diabetes Me | 2013 |
Chronic treatment with taurine ameliorates diabetes-induced dysfunction of nitric oxide-mediated neurogenic and endothelium-dependent corpus cavernosum relaxation in rats.
Topics: Acetylcholine; Animals; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Electric | 2014 |
Possible contribution of taurine to distorted glucagon secretion in intra-islet insulin deficiency: a metabolome analysis using a novel α-cell model of insulin-deficient diabetes.
Topics: Animals; Cell Line; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Gene Knockdown Techn | 2014 |
Antidepressant dose of taurine increases mRNA expression of GABAA receptor α2 subunit and BDNF in the hippocampus of diabetic rats.
Topics: Animals; Antidepressive Agents; Brain-Derived Neurotrophic Factor; Diabetes Mellitus, Experimental; | 2015 |
The quest for an animal model of diabetic nephropathy and the role of taurine deficiency.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Models, Animal; Female; Hu | 2015 |
Taurine can enhance the protective actions of metformin against diabetes-induced alterations adversely affecting renal function.
Topics: Animals; Blood Glucose; Cytoprotection; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Dru | 2015 |
Evaluation of the actions of metformin and taurine, singly and in combination, on metabolic and oxidative alterations caused by diabetes in rat erythrocytes and plasma.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Erythrocytes; Glycated Hemoglobin; Insulin; | 2015 |
Impact of light ethanol intake and of taurine, separately and together, on pathways of glucose metabolism in the kidney of diabetic rats.
Topics: Alcohol Drinking; Animals; Blood Glucose; Carbohydrate Metabolism; Diabetes Mellitus, Experimental; | 2015 |
Role of taurine on the actions of alcohol against systemic and cardiac biochemical changes in the diabetic rat.
Topics: Animals; Aspartate Aminotransferases; Biomarkers; Blood Glucose; Cholesterol; Creatine Kinase; Diabe | 2015 |
Region-specific cerebral metabolic alterations in streptozotocin-induced type 1 diabetic rats: an in vivo proton magnetic resonance spectroscopy study.
Topics: Animals; Aspartic Acid; Blood Glucose; Brain Chemistry; Corpus Striatum; Diabetes Mellitus, Experime | 2015 |
Taurine Supplementation Improves Erectile Function in Rats with Streptozotocin-induced Type 1 Diabetes via Amelioration of Penile Fibrosis and Endothelial Dysfunction.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Male; Penile Erection; Penis; R | 2016 |
Taurine and pioglitazone attenuate diabetes-induced testicular damage by abrogation of oxidative stress and up-regulation of the pituitary-gonadal axis.
Topics: Animals; Diabetes Mellitus, Experimental; Inflammation Mediators; Male; Oxidative Stress; Pioglitazo | 2016 |
Re: Taurine Supplementation Improves Erectile Function in Rats With Streptozotocin-Induced Type 1 Diabetes via Amelioration of Penile Fibrosis and Endothelial Dysfunction (J Sex Med 2016;13:778-785).
Topics: Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Erectile Dysfunction; Humans; M | 2016 |
Response and Rebuttal to Letter to the Editor regarding "Taurine Supplementation Improves Erectile Function in Rats with Streptozotocin-Induced Type 1 Diabetes via Amelioration of Penile Fibrosis and Endothelial Dysfunction".
Topics: Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Erectile Dysfunction; Humans; M | 2016 |
Antioxidant treatment ameliorates diabetes-induced dysfunction of the vas deferens in a rat model.
Topics: Animals; Antioxidants; Antipyrine; Diabetes Mellitus, Experimental; Edaravone; Male; Malondialdehyde | 2018 |
Dietary taurine supplementation prevents glial alterations in retina of diabetic rats.
Topics: Animals; Base Sequence; Diabetes Mellitus, Experimental; DNA Primers; Fluorescent Antibody Technique | 2009 |
The protective effects of taurine against early renal injury in STZ-induced diabetic rats, correlated with inhibition of renal LOX-1-mediated ICAM-1 expression.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Intercellular Adhesion Molecule-1; | 2008 |
Taurine rescues vascular endothelial dysfunction in streptozocin-induced diabetic rats: correlated with downregulation of LOX-1 and ICAM-1 expression on aortas.
Topics: Acetylcholine; Animals; Antioxidants; Aorta, Thoracic; Blotting, Western; Diabetes Mellitus, Experim | 2008 |
Hypoglycaemic, antioxidative and nephroprotective effects of taurine in alloxan diabetic rabbits.
Topics: Albuminuria; Animals; Antioxidants; Blood Glucose; Catalase; Creatinine; Diabetes Mellitus, Experime | 2009 |
Hyperglycemia not hypoglycemia alters neuronal dendrites and impairs spatial memory.
Topics: Animals; Brain Chemistry; Cerebral Cortex; Dendrites; Dendritic Spines; Diabetes Mellitus, Experimen | 2008 |
Protective effect of taurine on rats with experimental insulin-dependent diabetes mellitus.
Topics: Animals; Body Weight; C-Peptide; Cell Count; Diabetes Mellitus, Experimental; Diabetes Mellitus, Typ | 2008 |
The effects of taurine, taurine homologs and hypotaurine on cell and membrane antioxidative system alterations caused by type 2 diabetes in rat erythrocytes.
Topics: Animals; Antioxidants; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Male; Rats; Tauri | 2009 |
The effects of taurine, hypotaurine, and taurine homologs on erythrocyte morphology, membrane fluidity and cytoskeletal spectrin alterations due to diabetes, alcoholism and diabetes-alcoholism in the rat.
Topics: Alcoholism; Animals; Cytoskeleton; Diabetes Mellitus, Experimental; Erythrocytes; Male; Membrane Flu | 2009 |
Effects of streptozotocin-induced diabetes in domestic pigs with focus on the amino acid metabolism.
Topics: Alanine; Amino Acids; Amino Acids, Branched-Chain; Animals; Blood Glucose; Body Weight; C-Peptide; D | 2009 |
Effect of taurine supplementation on cytochrome P450 2E1 and oxidative stress in the liver and kidneys of rats with streptozotocin-induced diabetes.
Topics: Animals; Antioxidants; Blood Glucose; Blotting, Western; Body Weight; Cholesterol; Cytochrome P-450 | 2009 |
[Effects of early intervention with taurine on oxLDL/LOX-1 system and vascular endothelial dysfunction in young streptozotocin-induced diabetic rats].
Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Endothelium, Vascular; Male; Oxidat | 2009 |
Caffeine consumption attenuates neurochemical modifications in the hippocampus of streptozotocin-induced diabetic rats.
Topics: Animals; Blood Glucose; Caffeine; Central Nervous System Stimulants; Chronic Disease; Diabetes Melli | 2009 |
Hypoglycemic and hypolipidemic effects of an aqueous extract of Chamaerops humilis leaves in obese, hyperglycemic and hyperlipidemic Meriones shawi rats.
Topics: Animals; Arecaceae; Blood Glucose; Body Weight; Diabetes Complications; Diabetes Mellitus, Experimen | 2010 |
Effects of taurine on glial cells apoptosis and taurine transporter expression in retina under diabetic conditions.
Topics: Animals; Apoptosis; Cells, Cultured; Diabetes Mellitus, Experimental; Glucose; Membrane Glycoprotein | 2010 |
Comparative study of the binding characteristics to and inhibitory potencies towards PARP and in vivo antidiabetogenic potencies of taurine, 3-aminobenzamide and nicotinamide.
Topics: Animals; Benzamides; Blood Glucose; Catalytic Domain; Cholesterol; Diabetes Mellitus, Experimental; | 2010 |
Preventive effect of taurine on experimental type II diabetic nephropathy.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Nephrop | 2010 |
[Effects of taurine on hemorheology of rats with type 2 diabetes].
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Erythrocyte Defo | 2010 |
Taurine is more effective than melatonin on cytochrome P450 2E1 and some oxidative stress markers in streptozotocin-induced diabetic rats.
Topics: Animals; Blood Glucose; Cytochrome P-450 CYP2E1; Diabetes Mellitus, Experimental; Drug Evaluation, P | 2011 |
Protective effect of taurine on diabetic rat endothelial dysfunction.
Topics: Acetylcholine; Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Endothelium, Va | 2011 |
Antioxidant treatment may protect pancreatic beta cells through the attenuation of islet fibrosis in an animal model of type 2 diabetes.
Topics: Animals; Antioxidants; Apoptosis; Blood Glucose; Cyclic N-Oxides; Cytoprotection; Diabetes Mellitus, | 2011 |
Taurine exerts hypoglycemic effect in alloxan-induced diabetic rats, improves insulin-mediated glucose transport signaling pathway in heart and ameliorates cardiac oxidative stress and apoptosis.
Topics: Alloxan; Animals; Apoptosis; Biological Transport; Diabetes Mellitus, Experimental; Glucose; Glucose | 2012 |
Effect of Cordyceps sinensis and taurine either alone or in combination on streptozotocin induced diabetes.
Topics: Administration, Oral; Animals; Cordyceps; Diabetes Mellitus, Experimental; Glutathione; Male; Plant | 2012 |
Taurine ameliorates alloxan-induced diabetic renal injury, oxidative stress-related signaling pathways and apoptosis in rats.
Topics: Administration, Oral; Albumins; Alloxan; Animals; Antioxidants; Apoptosis; Blood Glucose; Blood Urea | 2012 |
Antidepressant effect of taurine in diabetic rats.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Body Weight; Depression; Diabetes Mellitus, Experi | 2012 |
Impaired synthesis contributes to diabetes-induced decrease in liver glutathione.
Topics: Acetylcysteine; Animals; Antioxidants; Diabetes Mellitus, Experimental; Glutathione; Glutathione Dis | 2012 |
Taurine attenuates maternal and embryonic oxidative stress in a streptozotocin-diabetic rat model.
Topics: Animals; Antioxidants; Blood Glucose; Diabetes Mellitus, Experimental; Disease Models, Animal; Embry | 2012 |
Antioxidant treatment with edaravone or taurine ameliorates diabetes-induced testicular dysfunction in the rat.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Animals; Antioxidants; Antipyrine; Deoxyguanosine; Diabetes Complicatio | 2012 |
Protective effects of taurine against alloxan-induced diabetic cataracts and refraction changes in New Zealand White rabbits.
Topics: Alloxan; Animals; Blood Glucose; Body Weight; Cataract; Diabetes Mellitus, Experimental; Hyperglycem | 2012 |
Taurine ameliorate alloxan induced oxidative stress and intrinsic apoptotic pathway in the hepatic tissue of diabetic rats.
Topics: Alloxan; Animals; Apoptosis; Blood Glucose; Body Weight; Caspase 3; Caspase 9; Cytochromes c; Diabet | 2013 |
Hepatic metabolism of sulfur amino acids in db/db mice.
Topics: Amino Acids, Sulfur; Animals; Betaine-Homocysteine S-Methyltransferase; Cysteine; Cysteine Dioxygena | 2013 |
Cardioprotective effects of cysteine alone or in combination with taurine in diabetes.
Topics: Animals; Cardiac Output; Cardiotonic Agents; Cholesterol; Cysteine; Diabetes Mellitus, Experimental; | 2013 |
Protection by taurine and thiotaurine against biochemical and cellular alterations induced by diabetes in a rat model.
Topics: Animals; Antioxidants; Blood Glucose; Catalase; Cell Shape; Cholesterol; Diabetes Mellitus, Experime | 2013 |
The effects of taurine and thiotaurine on oxidative stress in the aorta and heart of diabetic rats.
Topics: Animals; Aorta; Blood Glucose; Catalase; Cholesterol; Diabetes Mellitus, Experimental; Disease Model | 2013 |
Dissection of metabolic, vascular, and nerve conduction interrelationships in experimental diabetic neuropathy by cyclooxygenase inhibition and acetyl-L-carnitine administration.
Topics: Acetylcarnitine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase 2; Cyclooxygenase | 2002 |
Chronic taurine supplementation ameliorates oxidative stress and Na+ K+ ATPase impairment in the retina of diabetic rats.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Diet; Male; Oxidative Stress; Rats; | 2002 |
Comparative trial of N-acetyl-cysteine, taurine, and oxerutin on skin and kidney damage in long-term experimental diabetes.
Topics: Acetylcysteine; Animals; Anticoagulants; Blood Glucose; Collagen; Diabetes Mellitus, Experimental; D | 2003 |
Potential therapeutic effect of antioxidants in experimental diabetic retina: a comparison between chronic taurine and vitamin E plus selenium supplementations.
Topics: Animals; Antioxidants; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Dietary Suppleme | 2003 |
Effects of taurine and enalapril on kidney function of the hypertensive glucose-intolerant rat.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Newborn; Antihypertensive Agents; Body W | 2003 |
Taurine reduces mortality in diabetic rats: taurine and experimental diabetes mellitus.
Topics: Animals; Diabetes Mellitus, Experimental; Male; Rats; Rats, Wistar; Selenium; Streptozocin; Taurine; | 2003 |
The effect of dietary taurine supplementation on plasma and urinary free amino acid concentrations in diabetic rats.
Topics: Amino Acids; Animals; Diabetes Mellitus, Experimental; Diet; Male; Rats; Rats, Sprague-Dawley; Tauri | 2003 |
Hypoglycemic effects of taurine in the alloxan-treated rabbit, a model for type 1 diabetes.
Topics: Alloxan; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Disease Models, Animal; Hypoglycem | 2003 |
[Study on the intervening mechanism of taurine on streptozotocin-induced diabetic cataracts].
Topics: Animals; Blood Glucose; Cataract; Diabetes Mellitus, Experimental; Lipids; Male; Rats; Rats, Sprague | 2003 |
Taurine prevents streptozotocin impairment of hormone-stimulated glucose uptake in rat adipocytes.
Topics: Adipocytes; Adrenergic Agonists; Adrenergic Antagonists; Animals; Deoxyglucose; Diabetes Mellitus, E | 2004 |
Taurine increases glucose sensitivity of UCP2-overexpressing beta-cells by ameliorating mitochondrial metabolism.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Animals; Calcium; Cells, Cultured; Diabetes Mellitus, | 2004 |
Long-term taurine supplementation reduces mortality rate in streptozotocin-induced diabetic rats.
Topics: Animals; Antioxidants; Body Weight; Diabetes Mellitus, Experimental; Dietary Supplements; Male; Oxid | 2004 |
Taurine replacement attenuates hyperalgesia and abnormal calcium signaling in sensory neurons of STZ-D rats.
Topics: Adenosine Triphosphate; Animals; Blood Glucose; Body Weight; Caffeine; Calcium Signaling; Central Ne | 2005 |
Reactive oxygen species mediate high glucose-induced plasminogen activator inhibitor-1 up-regulation in mesangial cells and in diabetic kidney.
Topics: Animals; Antioxidants; Base Sequence; Buthionine Sulfoximine; Cells, Cultured; Diabetes Mellitus, Ex | 2005 |
Supplementation with N-acetylcysteine and taurine failed to restore glutathione content in liver of streptozotocin-induced diabetics rats but protected from oxidative stress.
Topics: Acetylcysteine; Animals; Antioxidants; Diabetes Mellitus, Experimental; Dioxygenases; Glutathione; L | 2005 |
Taurine may prevent diabetic rats from developing cardiomyopathy also by downregulating angiotensin II type2 receptor expression.
Topics: Animals; Apoptosis; Biomarkers; Blood Glucose; Blotting, Western; Cardiomyopathies; Carotid Artery, | 2005 |
HNE-dependent molecular damage in diabetic nephropathy and its possible prevention by N-acetyl-cysteine and oxerutin.
Topics: Acetylcysteine; Aldehydes; Animals; Apoptosis; Cell Division; Diabetes Mellitus, Experimental; Diabe | 2005 |
Oral glycine administration attenuates diabetic complications in streptozotocin-induced diabetic rats.
Topics: Administration, Oral; Aneurysm; Animals; Cerebral Arteries; Diabetes Mellitus, Experimental; Diabeti | 2006 |
Effects of dietary salt and fat on taurine excretion in healthy and diseased rats.
Topics: Animals; Blood Pressure; Diabetes Mellitus, Experimental; Dietary Fats; Female; Glucose; Hypertensio | 2006 |
Vanadyl sulfate, taurine, and combined vanadyl sulfate and taurine treatments in diabetic rats: effects on the oxidative and antioxidative systems.
Topics: Animals; Antioxidants; Blood Glucose; Diabetes Mellitus, Experimental; Hypoglycemic Agents; Liver; M | 2007 |
Early oxidative stress in testis and epididymal sperm in streptozotocin-induced diabetic mice: its progression and genotoxic consequences.
Topics: Animals; Antioxidants; Ascorbic Acid; Blood Glucose; Body Weight; Catalase; Diabetes Mellitus, Exper | 2007 |
Dietary taurine supplementation ameliorates diabetic retinopathy via anti-excitotoxicity of glutamate in streptozotocin-induced Sprague-Dawley rats.
Topics: Amino Acid Transport System X-AG; Animals; Blood Glucose; Blotting, Western; Body Weight; Diabetes M | 2008 |
Effects of taurine on the reactivity of aortas from diabetic rats.
Topics: Acetylcholine; Animals; Aorta, Thoracic; Calcium; Diabetes Mellitus, Experimental; Dose-Response Rel | 2008 |
In vitro osmoregulation of taurine in fetal mouse hearts.
Topics: Animals; Biological Transport; Chlorides; Choline; Diabetes Mellitus, Experimental; Fetal Heart; In | 1984 |
Taurine ameliorates chronic streptozocin-induced diabetic nephropathy in rats.
Topics: Animals; Chronic Disease; Collagen; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Glycati | 1995 |
Increased lipid fluidity in synaptosomes from brains of hyperosmolal rats.
Topics: Animals; Brain; Diabetes Mellitus, Experimental; Fatty Acids; Fluorescence Polarization; Hypernatrem | 1994 |
Immunohistochemical localization of taurine in rat renal tissue: studies in experimental disease states.
Topics: Animals; Diabetes Mellitus, Experimental; Immunohistochemistry; Kidney Diseases; Kidney Glomerulus; | 1993 |
Osmotically-induced nerve taurine depletion and the compatible osmolyte hypothesis in experimental diabetic neuropathy in the rat.
Topics: Aldehyde Reductase; Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Diabetic N | 1993 |
Restoration of endothelium-dependent relaxation in both hypercholesterolemia and diabetes by chronic taurine.
Topics: Acetylcholine; Animals; Aorta; Blood Glucose; Calcimycin; Cholesterol, LDL; Diabetes Mellitus, Exper | 1996 |
The effects of taurine in a rodent model of aging.
Topics: Aging; Animals; Blood Urea Nitrogen; Body Weight; Creatinine; Diabetes Mellitus, Experimental; Food, | 1996 |
Taurine and kynureninase.
Topics: Amino Acid Sequence; Animals; Binding Sites; Blood Glucose; Diabetes Mellitus; Diabetes Mellitus, Ex | 1996 |
Cardioprotective effect of taurine on calcium paradox in streptozotocin-induced diabetic rat hearts.
Topics: Adenine Nucleotides; Analysis of Variance; Animals; Calcium; Cardiotonic Agents; Cells, Cultured; Cr | 1996 |
Antihypercholesterolemic action of taurine on streptozotocin-diabetic rats or on rats fed a high cholesterol diet.
Topics: Animals; Anticholesteremic Agents; Body Weight; Caffeine; Cholesterol; Cholesterol, Dietary; Diabete | 1996 |
Taurine and diabetes. Humans and experimental models.
Topics: Animals; Arachidonic Acid; Aspirin; Blood Platelets; Diabetes Mellitus, Experimental; Diabetes Melli | 1996 |
Effect of diabetes on levels and uptake of putative amino acid neurotransmitters in rat retina and retinal pigment epithelium.
Topics: Analysis of Variance; Animals; Aspartic Acid; Diabetes Mellitus, Experimental; gamma-Aminobutyric Ac | 1996 |
Effect of taurine supplementation on the lipid peroxide formation and the activities of glutathione-related enzymes in the liver and islet of type I and II diabetic model mice.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitu | 1998 |
Effects of taurine supplementation on lipid peroxidation, blood glucose and blood lipid metabolism in streptozotocin-induced diabetic rats.
Topics: Animals; Blood Glucose; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Experimental; Dietary | 1998 |
Effect of dietary taurine supplementation on GSH and NAD(P)-redox status, lipid peroxidation, and energy metabolism in diabetic precataractous lens.
Topics: Adenosine Triphosphate; Animals; Cataract; Chromatography, High Pressure Liquid; Diabetes Mellitus, | 1999 |
Melatonin and taurine reduce early glomerulopathy in diabetic rats.
Topics: Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Diures | 1999 |
Acute effects of taurine on intracellular calcium in normal and diabetic cardiac myocytes.
Topics: Animals; Calcium; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Electric Stimulation; | 1999 |
Modelling cortical cataractogenesis 21: in diabetic rat lenses taurine supplementation partially reduces damage resulting from osmotic compensation leading to osmolyte loss and antioxidant depletion.
Topics: Adenosine Triphosphate; Amino Acids; Animals; Antioxidants; Blood Glucose; Cataract; Crystallins; Di | 1999 |
Modelling cortical cataractogenesis 22: is in vitro reduction of damage in model diabetic rat cataract by taurine due to its antioxidant activity?
Topics: Amino Acids; Animals; Antioxidants; Cataract; Culture Techniques; Diabetes Mellitus, Experimental; D | 1999 |
Taurine improves insulin sensitivity in the Otsuka Long-Evans Tokushima Fatty rat, a model of spontaneous type 2 diabetes.
Topics: Adipose Tissue; Analysis of Variance; Animals; Blood Urea Nitrogen; Body Weight; Cholesterol; Diabet | 2000 |
Improving effect of dietary taurine on marked hypercholesterolemia induced by a high-cholesterol diet in streptozotocin-induced diabetic rats.
Topics: Animals; Cholesterol; Cholesterol 7-alpha-Hydroxylase; Cholesterol, Dietary; Diabetes Mellitus, Expe | 1999 |
Effect of experimental diabetes on GABA-mediated inhibition of neurally induced contractions in rat isolated trachea.
Topics: Acetylcholine; Animals; Baclofen; Bicuculline; Blood Glucose; Body Weight; Diabetes Mellitus, Experi | 2000 |
The effect of topical insulin on the release of excitotoxic and other amino acids from the rat cerebral cortex during streptozotocin-induced hyperglycemic ischemia.
Topics: Administration, Topical; Animals; Aspartic Acid; Blood Glucose; Brain Ischemia; Cerebral Cortex; Dia | 2000 |
Evaluation of alpha(1)-adrenoceptor antagonist on diabetes-induced changes in peripheral nerve function, metabolism, and antioxidative defense.
Topics: Adrenergic alpha-Antagonists; Animals; Antioxidants; Blood Glucose; Blood Pressure; Body Weight; Cre | 2000 |
Low taurine, gamma-aminobutyric acid and carnosine levels in plasma of diabetic pregnant rats: consequences for the offspring.
Topics: Animals; Blood Glucose; Carnosine; Diabetes Mellitus, Experimental; Female; Fetal Blood; gamma-Amino | 2001 |
Depletion of taurine in experimental diabetic neuropathy: implications for nerve metabolic, vascular, and functional deficits.
Topics: Animals; Anti-Bacterial Agents; Blood Flow Velocity; Blood Glucose; Blood Pressure; Body Weight; Car | 2001 |
Antioxidants attenuate early up regulation of retinal vascular endothelial growth factor in streptozotocin-diabetic rats.
Topics: Alternative Splicing; Animals; Antioxidants; Ascorbic Acid; Blood Glucose; Dehydroascorbic Acid; Dia | 2001 |
Taurine counteracts oxidative stress and nerve growth factor deficit in early experimental diabetic neuropathy.
Topics: Aldehydes; Animals; Ascorbic Acid; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Diab | 2001 |
Taurine fluxes in insulin dependent diabetes mellitus and rehydration in streptozotocin treated rats.
Topics: Animals; Brain; Brain Edema; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Ke | 2000 |
Immunohistochemical localization of insulin in pancreatic beta-cells of taurine-supplemented or taurine-depleted diabetic rats.
Topics: Animals; beta-Alanine; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Dietary Suppleme | 2000 |
Effect of taurine and beta-alanine on morphological changes of pancreas in streptozotocin-induced rats.
Topics: Animals; beta-Alanine; Diabetes Mellitus, Experimental; Dietary Supplements; Islets of Langerhans; M | 2000 |
Changes in taurine content in heart and other organs of diabetic rats.
Topics: Animals; Diabetes Mellitus, Experimental; Fasting; Kidney; Liver; Male; Muscles; Myocardium; Rats; T | 1979 |
Cerebral taurine transport is increased during streptozocin-induced diabetes in rats.
Topics: Animals; Biological Transport; Brain; Diabetes Mellitus, Experimental; Hyperglycemia; Insulin; Male; | 1992 |
Diabetes-induced bile acid composition changes in rat bile determined by high performance liquid chromatography.
Topics: Animals; Bile; Bile Acids and Salts; Cholesterol; Chromatography, High Pressure Liquid; Diabetes Mel | 1991 |
Nonosmotic diabetic cataracts.
Topics: Aldehyde Reductase; Animals; Cataract; Diabetes Mellitus, Experimental; Imidazoles; Imidazolidines; | 1990 |
Supplemental taurine in diabetic rats: effects on plasma glucose and triglycerides.
Topics: Amino Acids; Animals; Blood Glucose; Body Weight; Cholesterol; Diabetes Mellitus, Experimental; Orga | 1990 |
Studies on cholesterol metabolism in experimental diabetic rat.
Topics: Animals; Bile Acids and Salts; Carbon Isotopes; Cholesterol; Diabetes Mellitus, Experimental; Dietar | 1970 |